{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:57:46Z","timestamp":1790751466312,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T00:00:00Z","timestamp":1536537600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13071-018-3083-2","type":"journal-article","created":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T10:33:22Z","timestamp":1536575602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Efficacy of two formulations of afoxolaner (NexGard\u00ae and NexGard Spectra\u00ae) for the treatment of generalised demodicosis in dogs, in veterinary dermatology referral centers in Europe"],"prefix":"10.1186","volume":"11","author":[{"given":"Wilfried","family":"Lebon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Beccati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Bourdeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Brement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Bruet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Cekiera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Crosaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Darmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Guillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Mosca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Pin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw","family":"Popiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Pomorska Handwerker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Tielemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Beugnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9na\u00efg","family":"Halos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,10]]},"reference":[{"key":"3083_CR1","first-page":"809","volume-title":"Helminths, arthropods, and protozoa of domesticated animals","author":"E Soulsby","year":"1982","unstructured":"Soulsby E. Helminths, arthropods, and protozoa of domesticated animals. 7th ed. London: Bailli\u00e8re Tindall; 1982. p. 809.","edition":"7"},{"key":"3083_CR2","first-page":"304","volume-title":"Muller and Kirk\u2019s Small Animal Dermatology","author":"WH Miller Jr","year":"2013","unstructured":"Miller WH Jr, Griffin CE, Campbell KL. Muller and Kirk\u2019s Small Animal Dermatology. 7th ed. St. Louis: Elsevier Health; 2013. p. 304\u201313.","edition":"7"},{"key":"3083_CR3","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1365-3164.2009.00790.x","volume":"20","author":"R Mueller","year":"2009","unstructured":"Mueller R, Meyer D, Bensignor E, Sauter-Louis C. Treatment of canine generalised demodecosis with a \u201cspot-on\u201d formulation containing 10% moxidectine and 2.5% imidacloprid (Advocate, Bayer Healthcare). Vet Dermatol. 2009;20:441\u20136.","journal-title":"Vet Dermatol"},{"key":"3083_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1365-3164.2011.01026.x","volume":"23","author":"RS Mueller","year":"2012","unstructured":"Mueller RS, Bensignor E, Ferrer L, Holm B, Lemarie S, Paradis M, et al. Treatment of demodicosis in dogs: 2011 clinical practice guidelines. Vet Dermatol. 2012;23:86\u201396.","journal-title":"Vet Dermatol"},{"key":"3083_CR5","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/vde.12136","volume":"25","author":"L Ferrer","year":"2014","unstructured":"Ferrer L, Ravera I, Silbermayr K. Immunology and pathogenesis of canine demodicosis. Vet Dermatol. 2014;25:427\u2013e65.","journal-title":"Vet Dermatol"},{"key":"3083_CR6","first-page":"179","volume-title":"A Practical Guide to Canine Dermatology","author":"E Guagu\u00e8re","year":"2008","unstructured":"Guagu\u00e8re E, Beugnet F. Parasitic skin conditions. In: Guagu\u00e8re E, Pr\u00e9laud P, Craig M, editors. A Practical Guide to Canine Dermatology. Paris: Kalianxis; 2008. p. 179\u2013226."},{"key":"3083_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1365-3164.2004.00344.x","volume":"15","author":"RS Mueller","year":"2004","unstructured":"Mueller RS. Treatment protocols for demodicosis: an evidence-based review. Vet Dermatol. 2004;15:75\u201389.","journal-title":"Vet Dermatol"},{"key":"3083_CR8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0304-4017(84)90051-7","volume":"16","author":"SD Folz","year":"1984","unstructured":"Folz SD, Kakuk TJ, Hencke CL, Rector DL, Tesar FB. Clinical evaluation of amitraz as a treatment for canine demodecosis. Vet Parasitol. 1984;16:335\u201341.","journal-title":"Vet Parasitol"},{"key":"3083_CR9","first-page":"E1","volume":"34","author":"R Mueller","year":"2012","unstructured":"Mueller R. An update on the therapy of canine demodicosis. Compend Conti Educ Vet. 2012;34:E1\u20134.","journal-title":"Compend Conti Educ Vet"},{"key":"3083_CR10","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1365-3164.2009.00803.x","volume":"20","author":"T Paterson","year":"2009","unstructured":"Paterson T, Halliwell R, Fields P, Lanza Louw M, Louw J, Ball G, et al. Treatment of canine-generalised demodecosis: a blind, randomized clinical trial comparing the efficacy of Advocate (Bayer Animal Health) with ivermectin. Vet Dermatol. 2009;20:447\u201355.","journal-title":"Vet Dermatol"},{"key":"3083_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1051\/parasite\/2016014","volume":"23","author":"F Beugnet","year":"2016","unstructured":"Beugnet F, Halos L, Larsen D, de Vos C. Efficacy of oral afoxolaner for the treatment of canine generalised demodicosis. Parasite. 2016;23:14.","journal-title":"Parasite"},{"key":"3083_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1051\/parasite\/2016026","volume":"23","author":"F Beugnet","year":"2016","unstructured":"Beugnet F, de Vos C, Liebenberg L, Halos L, Diane D, Fourie J. Efficacy of afoxolaner in a clinical field study in dogs naturally infested with Sarcoptes scabiei. Parasite. 2016;23:26.","journal-title":"Parasite"},{"key":"3083_CR13","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1186\/s13071-016-1924-4","volume":"9","author":"D Carithers","year":"2016","unstructured":"Carithers D, Crawford J, de Vos C, Lotriet A, Fourie J. Assessment of afoxolaner efficacy against Otodectes cynotis infestations of dogs. Parasit Vectors. 2016;9:635.","journal-title":"Parasit Vectors"},{"key":"3083_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13071-015-0775-8","volume":"8","author":"J Fourie","year":"2015","unstructured":"Fourie J, Liebenberg JE, Horak IG, Taenzler J, Heckeroth AR, Fr\u00e9nais R. Efficacy of orally administered fluralaner (Bravecto\u2122) or topically applied imidacloprid\/moxidectin (Advocate\u00ae) against generalized demodicosis in dogs. Parasit Vectors. 2015;8:187.","journal-title":"Parasit Vectors"},{"key":"3083_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.vetpar.2016.02.027","volume":"222","author":"RH Six","year":"2016","unstructured":"Six RH, Becskei C, Mazaleski MM, Fourie J, Mahabir SP, Myers MR, Slootmans N. Efficacy of sarolaner, a novel oral isoxazoline, against two common mite infestations in dogs: Demodex spp. and Otodectes cynotis. Vet Parasitol. 2016;222:62\u20136.","journal-title":"Vet Parasitol"},{"key":"3083_CR16","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s13071-016-1670-7","volume":"9","author":"J Taenzler","year":"2016","unstructured":"Taenzler J, Liebenberg J, Roepke RKA, Fr\u00e9nais R, Heckeroth AR. Efficacy of fluralaner administered either orally or topically for the treatment of naturally acquired Sarcoptes scabiei var. canis infestation in dogs. Parasit Vectors. 2016;9:392.","journal-title":"Parasit Vectors"},{"key":"3083_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13071-016-1954-y","volume":"10","author":"J Taenzler","year":"2017","unstructured":"Taenzler J, de Vos C, Roepke RKA, Fr\u00e9nais R, Heckeroth AR. Efficacy of fluralaner against Otodectes cynotis infestations in dogs and cats. Parasit Vectors. 2017;10:30.","journal-title":"Parasit Vectors"},{"key":"3083_CR18","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/vde.12390","volume":"27","author":"HS Han","year":"2016","unstructured":"Han HS, Noli C, Cena T. Efficacy and duration of action of oral fluralaner and spot-on moxidectin\/imidacloprid in cats infested with Lynxacarus radovskyi. Vet Dermatol. 2016;27:474\u2013e127.","journal-title":"Vet Dermatol"},{"key":"3083_CR19","volume-title":"VICH Topic GL9 (GCP). Guideline on Good Clinical Practices. The European Agency for the Evaluation of Medicinal Products (EMWA\/CVMP\/VICH\/595\/98-Final)","author":"EMEA","year":"2000","unstructured":"EMEA. VICH Topic GL9 (GCP). Guideline on Good Clinical Practices. The European Agency for the Evaluation of Medicinal Products (EMWA\/CVMP\/VICH\/595\/98-Final). 2000. \n                    http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/10\/WC500004343.pdf\n                    \n                  . Accessed 28 Mar 2018."},{"key":"3083_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1365-3164.2008.00728.x","volume":"20","author":"J Rybn\u00ed\u010dek","year":"2009","unstructured":"Rybn\u00ed\u010dek J, Lau-Gillard PJ, Harvey R, Hill PB. Further validation of a pruritus severity scale for use in dogs. Vet Dermatol. 2009;20:115\u201322.","journal-title":"Vet Dermatol"},{"key":"3083_CR21","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/vde.12524","volume":"29","author":"L Duangkaew","year":"2018","unstructured":"Duangkaew L, Larsuprom L, Anukkul P, Lekcharoensuk C, Chen C. A field trial in Thailand of the efficacy of oral fluralaner for the treatment of dogs with generalised demodicosis. Vet Dermatol. 2018;29:208\u2013e74.","journal-title":"Vet Dermatol"},{"key":"3083_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/vde.12526","volume":"29","author":"C Becskei","year":"2018","unstructured":"Becskei C, Cuppens O, Mahabir SP. Efficacy and safety of sarolaner against generalised demodicosis in dogs in European countries: a non-inferiority study. Vet Dermatol. 2018;29:203\u2013e72.","journal-title":"Vet Dermatol"},{"key":"3083_CR23","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1186\/s13071-017-2472-2","volume":"10","author":"DE Snyder","year":"2017","unstructured":"Snyder DE, Wiseman S, Liebenberg JE. Efficacy of lotilaner (Credelio\u2122), a novel oral isoxazoline against naturally occurring mange mite infestations in dogs caused by Demodex spp. Parasit Vectors. 2017;10:532.","journal-title":"Parasit Vectors"},{"key":"3083_CR24","first-page":"10","volume":"29","author":"DG Bowden","year":"2017","unstructured":"Bowden DG, Outerbridge CA, Kissel MB, Baron JN, White SD. Canine demodicosis: a retrospective study of a veterinary hospital population in California, USA (2000\u20132016). Vet Dermatol. 2017;29:10\u20139.","journal-title":"Vet Dermatol"},{"key":"3083_CR25","first-page":"991","volume":"57","author":"J Bajwa","year":"2016","unstructured":"Bajwa J. Canine pododermatitis. Can Vet J. 2016;57:991\u20133.","journal-title":"Can Vet J"},{"key":"3083_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1051\/parasite\/2013046","volume":"20","author":"J Fourie","year":"2013","unstructured":"Fourie J, Dumont P, Halos L, Beugnet F, Pollmeier M. Efficacy of a topical application of Certifect\u00ae (fipronil 6.26% w\/v, amitraz 7.48% w\/v, (S)-methoprene 5.63% w\/v) for the treatment of canine generalised demodicosis. Parasite. 2013;20:46.","journal-title":"Parasite"},{"key":"3083_CR27","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1016\/S0895-4356(01)00457-7","volume":"54","author":"J Dunbar-Jacob","year":"2001","unstructured":"Dunbar-Jacob J, Mortimer-Stephens MK. Treatment adherence in chronic disease. J Clin Epidemiol. 2001;54:S57\u201360.","journal-title":"J Clin Epidemiol"},{"key":"3083_CR28","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/vde.12453","volume":"28","author":"CM Zewe","year":"2017","unstructured":"Zewe CM, Altet L, Lam ATH, Ferrer L. Afoxolaner and fluralaner treatment do not impact on cutaneous Demodex populations of healthy dogs. Vet Dermatol. 2017;28:468\u2013e107.","journal-title":"Vet Dermatol"}],"container-title":["Parasites & Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-018-3083-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13071-018-3083-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-018-3083-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T19:15:53Z","timestamp":1568056553000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-018-3083-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,10]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3083"],"URL":"https:\/\/doi.org\/10.1186\/s13071-018-3083-2","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,10]]},"assertion":[{"value":"5 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animals enrolled in the study were privately owned dogs and an informed consent and agreement for participation in the study was obtained from each owner before enrollment of the dog.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This clinical study was funded by Boehringer Ingelheim Animal Health, 29 Avenue Tony Garnier, 69007 Lyon, France. WL, DL, ET, FB and LH are employees of Boehringer Ingelheim Animal Health. JG, CD, OC, PB, VB, TB, DP, MM, JP, AC, DPH and MB are independent investigators contracted for this study and declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"506"}}